Use of runx3 and mir-532-5p as cancer markers and therapeutic targets

Dave S.B. Hoon; Minoru Kitago

Use of runx3 and mir-532-5p as cancer markers and therapeutic targets

Dave S.B. Hoon
, Minoru Kitago

Research output: Other contribution

Original language	American English
State	Published - Jun 18 2009

Disciplines

Biology
Pharmacology

Cite this

@misc{764e197a3b46431ea27c77f7137d595c,

title = "Use of runx3 and mir-532-5p as cancer markers and therapeutic targets",

author = "Hoon, \{Dave S.B.\} and Minoru Kitago",

note = "The invention relates to methods for cancer diagnosis, prognosis, and treatment based on the expression or activity levels of RUNX3 and miR-532-5p. Also disclosed is a method of reducing the inhibition of RUNX3 by miR-532-5p with an agent that interferes with the interaction between RUNX3 and miR-532-5p transcripts.",

year = "2009",

month = jun,

day = "18",

language = "American English",

type = "Other",

}

TY - GEN

T1 - Use of runx3 and mir-532-5p as cancer markers and therapeutic targets

AU - Hoon, Dave S.B.

AU - Kitago, Minoru

N1 - The invention relates to methods for cancer diagnosis, prognosis, and treatment based on the expression or activity levels of RUNX3 and miR-532-5p. Also disclosed is a method of reducing the inhibition of RUNX3 by miR-532-5p with an agent that interferes with the interaction between RUNX3 and miR-532-5p transcripts.

PY - 2009/6/18

Y1 - 2009/6/18

UR - https://patents.google.com/patent/US20100227319A1/en

M3 - Other contribution

ER -

Use of runx3 and mir-532-5p as cancer markers and therapeutic targets

Disciplines

Other files and links

Cite this